Author page: Ella Ye

In the first half of 2020, the revolutionary global clinical trial for brain cancer patients, GBM AGILE, continues to make impressive progress and achieve milestones. AFCR supported its conception in 2013 to expeditiously develop new effective treatments for GBM brain cancer patients…

“Should I get a second opinion?” It’s a popular question that many cancer patients ask themselves when faced with their diagnosis and treatment options. So when, why and how should someone go about getting this second opinion? When: In most instances of cancer, (not…

FOR IMMEDIATE RELEASE: 4 August 2020   CONTACTS: Asian Fund for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@afcr.org   Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: marco.raccuia@hugillandip.com   Applications Open for the Asian Fund for Cancer Research’s BRACE Award Venture Competition   First of…

It has long been believed that herbs and spices offer far more than delicious flavor. Cultures around the world have used herbs and spices for a large array of activities, from medical treatment to religious practices. In fact, it was spices that…

We have completed six studies in the US and now we are doing an international clinical trial with a target population of hepatocellular carcinoma, which is the major type of liver cancer in Asia... Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309656/